|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.09 USD | +0.40% |
|
+3.35% | +9.48% |
| 07-15 | Jefferies Adjusts Price Target on Globe Life to $132 From $130, Hold Rating Maintained | MT |
| 07-15 | Truist Initiates Globe Life at Buy With $150 Price Target | MT |
| Capitalization | 10.08B 8.65B 8.06B 7.5B 13.83B 868B 15.44B 97.33B 36.74B 407B 37.8B 37.02B 1,496B | P/E ratio 2025 * |
9.1x | P/E ratio 2026 * | 8.27x |
|---|---|---|---|---|---|
| Enterprise value | 13.3B 11.41B 10.63B 9.89B 18.25B 1,145B 20.38B 128B 48.48B 537B 49.88B 48.85B 1,974B | EV / Sales 2025 * |
2.2x | EV / Sales 2026 * | 2.18x |
| Free-Float |
80.4% | Yield 2025 * |
0.86% | Yield 2026 * | 0.91% |
More valuation ratios
* Estimated data
More news
Last Transcript: Globe Life Inc.
More recommendations
More press releases
More news
| 1 day | +0.40% | ||
| 1 week | +3.35% | ||
| Current month | -1.77% | ||
| 1 month | +1.99% | ||
| 3 months | +0.69% | ||
| 6 months | +3.20% | ||
| Current year | +9.48% |
| 1 week | 117.3 |  | 122.38 |
| 1 month | 116.73 | | 125.19 |
| Current year | 109.38 | | 133.76 |
| 1 year | 86.1 | | 133.76 |
| 3 years | 38.95 | | 133.76 |
| 5 years | 38.95 | | 133.76 |
| 10 years | 38.95 | | 133.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Darden
CEO | Chief Executive Officer | 54 | 2022-12-31 |
Frank Svoboda
CEO | Chief Executive Officer | 63 | 2022-12-31 |
Thomas Kalmbach
DFI | Director of Finance/CFO | 60 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Svoboda
CHM | Chairman | 63 | 2023-04-26 |
| Director/Board Member | 73 | 2013-02-26 | |
James Darden
CHM | Chairman | 54 | 2023-04-26 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 14.47% | 378 M€ | -9.74% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.40% | +3.35% | +38.33% | +21.48% | 10.08B | ||
| +5.13% | +4.24% | +75.54% | +65.21% | 135B | ||
| +1.70% | -1.22% | +26.12% | -17.80% | 91.78B | ||
| -0.55% | +0.08% | -16.81% | +32.54% | 67.8B | ||
| -0.48% | +1.33% | +2.07% | +65.35% | 38.92B | ||
| -0.04% | 0.00% | -18.40% | +40.23% | 27.03B | ||
| -0.80% | -2.55% | +7.75% | +51.93% | 20.81B | ||
| -1.64% | -2.57% | +13.96% | +36.25% | 18.5B | ||
| +0.73% | +0.77% | +26.87% | +32.84% | 17.99B | ||
| +0.95% | +4.64% | +18.11% | +128.98% | 11.55B | ||
| Average | +0.54% | +0.68% | +17.35% | +45.70% | 43.98B | |
| Weighted average by Cap. | +1.76% | +1.15% | +28.56% | +38.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.05B 5.19B 4.83B 4.5B 8.3B 521B 9.27B 58.4B 22.05B 244B 22.68B 22.21B 898B | 6.36B 5.46B 5.08B 4.73B 8.73B 548B 9.75B 61.43B 23.19B 257B 23.86B 23.36B 944B |
| Net income | 1.11B 953M 888M 826M 1.52B 95.65B 1.7B 10.73B 4.05B 44.85B 4.17B 4.08B 165B | 1.17B 1B 932M 867M 1.6B 100B 1.79B 11.26B 4.25B 47.09B 4.37B 4.28B 173B |
| Net Debt | 3.22B 2.76B 2.57B 2.4B 4.42B 277B 4.93B 31.1B 11.74B 130B 12.08B 11.83B 478B | 3.78B 3.24B 3.02B 2.81B 5.18B 325B 5.79B 36.46B 13.76B 152B 14.16B 13.87B 560B |
More financial data
* Estimated data
Employees
3,732
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 122.09 $ | +0.40% | 591,766 |
| 25-07-17 | 121.60 $ | +1.42% | 541,834 |
| 25-07-16 | 119.90 $ | +1.83% | 404,700 |
| 25-07-15 | 117.74 $ | -2.44% | 443,065 |
| 25-07-14 | 120.69 $ | +2.17% | 457,218 |
Delayed Quote Nyse, July 18, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
122.09USD
Average target price
146.91USD
Spread / Average Target
+20.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition